Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis
Storage Instructions Lyophilized: 20 C in dry, dark place
CJC-1295 with DAC (drug affinity complex)
N.BartoschB.IvanovA
S.KhanO
Dysbiosis, through the lack of appropriate immunoregulatory and barrier factors, such as, e.g., short-chain fatty acids, causes inappropriate activation of the immune system, resulting in epithelial inflammation, epithelial barrier damage and disease development [55, 57,58,59,60,61]
US$ 26.91
US$ 27.58
US$ 24.18
US$ 21.50
US$ 20.22
US$ 26.26
